ImaCor, an innovator in critical care devices, has changed the future of hemodynamic management with the development of the first TEE monitoring device.

ImaCor’s management team is dedicated to the common goal of improving patient care while reducing its cost. We believe the ImaCor ClariTEE technology accomplishes both.

ImaCor was founded in 2000 dedicated to improving patient care in the intensive care and perioperative areas of hospitals. ImaCor designs, manufactures and distributes advanced solutions for assessing and monitoring cardiac function in ICU and perioperative patients.

ImaCor’s development of the world’s first imaging monitor enables the assessment and monitoring of cardiac function in critically ill patients at the bedside. The ClariTEE™, a miniaturized disposable TEE probe, enables direct visualization of cardiac function and can remain indwelling for up to 72-hours.